Business Description
HCW Biologics Inc
NAICS : 541714
SIC : 2834
ISIN : US40423R1059
Description
HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.57 | |||||
| Equity-to-Asset | 0.47 | |||||
| Debt-to-Equity | 0.47 | |||||
| Debt-to-EBITDA | -0.27 | |||||
| Piotroski F-Score | 1/9 | |||||
| Altman Z-Score | -4.12 | |||||
| Beneish M-Score | 3.17 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -17.9 | |||||
| 3-Year EBITDA Growth Rate | -52.8 | |||||
| 3-Year EPS without NRI Growth Rate | -51.1 | |||||
| 3-Year FCF Growth Rate | -29.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 24.7 | |||||
| 9-Day RSI | 32.84 | |||||
| 14-Day RSI | 38.61 | |||||
| 6-1 Month Momentum % | -5.56 | |||||
| 12-1 Month Momentum % | 25.93 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.73 | |||||
| Quick Ratio | 0.73 | |||||
| Cash Ratio | 0.41 | |||||
| Days Sales Outstanding | 93.09 | |||||
| Days Payable | 442.54 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -8 | |||||
| Shareholder Yield % | 0.11 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 19.74 | |||||
| Operating Margin % | -904.93 | |||||
| Net Margin % | -879.49 | |||||
| FCF Margin % | -1010.45 | |||||
| ROE % | -91.92 | |||||
| ROA % | -64.43 | |||||
| ROIC % | -143.04 | |||||
| ROC (Joel Greenblatt) % | -175.5 | |||||
| ROCE % | -73.64 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 18.48 | |||||
| PB Ratio | 3.78 | |||||
| Price-to-Tangible-Book | 3.78 | |||||
| EV-to-EBIT | -2.34 | |||||
| EV-to-Forward-EBIT | -2.74 | |||||
| EV-to-EBITDA | -2.46 | |||||
| EV-to-Revenue | 20.38 | |||||
| EV-to-Forward-Revenue | 81.17 | |||||
| EV-to-FCF | -2.02 | |||||
| Earnings Yield (Greenblatt) % | -42.74 | |||||
| FCF Yield % | -54.24 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:HCWB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
HCW Biologics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 2.842 | ||
| EPS (TTM) ($) | -0.7 | ||
| Beta | 0 | ||
| Volatility % | 75.56 | ||
| 14-Day RSI | 38.61 | ||
| 14-Day ATR ($) | 0.132937 | ||
| 20-Day SMA ($) | 1.584525 | ||
| 12-1 Month Momentum % | 25.93 | ||
| 52-Week Range ($) | 0.91 - 2.32 | ||
| Shares Outstanding (Mil) | 37.82 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
HCW Biologics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
HCW Biologics Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
HCW Biologics Inc Frequently Asked Questions
What is HCW Biologics Inc(HCWB)'s stock price today?
The current price of HCWB is $1.40. The 52 week high of HCWB is $2.32 and 52 week low is $0.91.
When is next earnings date of HCW Biologics Inc(HCWB)?
The next earnings date of HCW Biologics Inc(HCWB) is 2024-05-09 Est..
Does HCW Biologics Inc(HCWB) pay dividends? If so, how much?
HCW Biologics Inc(HCWB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers